SCHEMBL19833045

SCHEMBL19833045

O=c1c2ccccc2nc(/C=C/c2ccc(Cl)cc2)n1-c1cccc(O)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.85
KMT2A Q03164 8/20 0.85
POLB P06746 5/20 0.85
KDM4E B2RXH2 3/20 0.85
ALDH1A1 P00352 3/20 0.85
TDP1 Q9NUW8 2/20 0.85
BLM P54132 1/20 0.85
L3MBTL1 Q9Y468 1/20 0.85
TP53 P04637 5/20 0.76
MAPT P10636 4/20 0.68
LMNA P02545 3/20 0.68
GLA P06280 1/20 0.68
PKM P14618 1/20 0.68
MCL1 Q07820 1/20 0.68
KLK7 P49862 1/20 0.67
GAA P10253 2/20 0.64
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
RXFP1 Q9HBX9 1/20 0.61
THRB P10828 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16024106 0.92 MEN1 (0.91) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL1962693 0.90 TP53 (0.76) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL1962692 0.90 TP53 (0.76) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL17489619 0.89 MEN1 (0.85) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL17487046 0.89 MEN1 (0.85) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL16024136 0.88 MEN1 (0.83) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL17489632 0.87 MEN1 (0.66) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL17489620 0.86 MEN1 (0.80) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL16024108 0.86 MEN1 (0.80) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL16024079 0.85 MEN1 (0.80) MEN1KMT2APOLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964618-B1 QUINAZOLINONE ANTIBIOTICS UNIV NOTRE DAME DU LAC (US) 2019-09-04 EP disclosed
US-20180029997-A1 QUINAZOLINONE ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180029997-A1 QUINAZOLINONE ANTIBIOTICS Q6ZSR9, TOP2A, CEP170 MEN1 4776/4885KMT2A 2228/4885POLB 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.